Eric Gordon, MD

Eric Gordon, MD

Dr. Gordon has been a distinguished medicinal chemist, company founder and senior executive since the early 1970s. He was Director of medicinal chemistry at the Squibb Institute for Medical Research and later Bristol-Myers Squibb, where he worked for 18 years. Since the early 1990s Eric has participated in the building of several successful biotech companies including, Affymax Versicor (later Vicuron Pharmaceuticals, which was acquired by Pfizer in 2005), and Sunesis Pharmaceuticals. Eric has authored more than 200 U.S. patents and scientific manuscripts, including two manuscripts that had the honor of being the most frequently cited chemistry papers in the world between 1994 and 1996.